Log in to save to my catalogue

Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics

Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3128742447

Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics

About this item

Full title

Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics

Publisher

Singapore: Codon Publications

Journal title

Allergologia et immunopathologia, 2024-01, Vol.52 (6), p.76-78

Language

English

Formats

Publication information

Publisher

Singapore: Codon Publications

More information

Scope and Contents

Contents

To evaluate the response to Tezepelumab in real clinical practice, we performed an analysis of the clinical, functional, and inflammatory characteristics of 13 patients with severe asthma after completing four doses of Tezepelumab was performed. When comparing clinical parameters such as asthma control test (ACT), FENO value, exacerbations in the l...

Alternative Titles

Full title

Four-month real-life response to Tezepelumab in patients with multi-failure to other biologics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3128742447

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3128742447

Other Identifiers

ISSN

0301-0546,1578-1267

E-ISSN

0301-0546,1578-1267

DOI

10.15586/aei.v52i6.1161

How to access this item